Skip to main content

Lumiere to Market Cerno's Mass Spec Software in China

NEW YORK (GenomeWeb News) - Cerno Bioscience said today that it has signed an agreement with Lumiere Technology, under which Lumiere will distribute Cerno’s software in China.
 
Cerno, a developer of mass spectrometry analysis software based in Danbury, Conn., said its MassWorks software can “dramatically improve the amount of information obtainable from and reduce the amount of time required of many MS experiments.”
 
Cerno said the agreement with the Beijing-based Lumiere will exploit the increasing demand for mass spec products in China’s biopharmaceutical and environmental industries.
 
Financial terms of the agreement were not released.
 

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.